Supported Releases: These releases have been certified by Bloomberg’s Enterprise Products team for use by Bloomberg customers. Experimental Releases: These releases have not yet been certified for use ...
Determinants of trial completion, termination, and efficacy in solid tumor immunotherapy: Mapping IO clinical trial evolution from 2015-2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results